Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Malmberg

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Vox Sanguinis|January 1, 1978
Intravenous gamma-globulin infusions in patients with hypo-gamma-globulinemia: prevention of adverse reactions with corticosteroidsD Gislason, L A Hanson, H Kjellman, et al.
The Annals of Thoracic Surgery|December 1, 1984
Hospital mortality and long-term survival in relation to preoperative function in elderly patients with bronchogenic carcinomaH Berggren, R Ekroth, R Malmberg, et al.
Cureus|August 9, 2021
A Rare Case of Inadvertent Iatrogenic Osmotic Demyelination SyndromeKasopefoluwa O Akinbamijo, Ifeoluwa R Malmberg, Candace Griffith, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Lung cancer in West Sweden 1976-1985. A study of trends and survival with special reference to surgical treatmentR Malmberg, B Bergman, I Branehög, et al.
Proceedings of the Clinical Dialysis and Transplant Forum|January 1, 1973
Long-term kidney preservation with a new plasma perfusateL H Toledo-Pereyra, R M Condie, R Malmberg, et al.
Surgery, Gynecology & Obstetrics|June 1, 1974
A fibrinogen-free plasma perfusate for preservation of kidneys for one hundred and twenty hoursL H Toledo-Pereyra, R M Condie, R Malmberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugsJ B Sørensen, H H Hansen, P Dombernowsky, et al.
European Journal of Haematology|May 21, 2016
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencingErik B R Malmberg, Sara Ståhlman, Anna Rehammar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Vox Sanguinis|January 1, 1978
Intravenous gamma-globulin infusions in patients with hypo-gamma-globulinemia: prevention of adverse reactions with corticosteroidsD Gislason, L A Hanson, H Kjellman, et al.
The Annals of Thoracic Surgery|December 1, 1984
Hospital mortality and long-term survival in relation to preoperative function in elderly patients with bronchogenic carcinomaH Berggren, R Ekroth, R Malmberg, et al.
Cureus|August 9, 2021
A Rare Case of Inadvertent Iatrogenic Osmotic Demyelination SyndromeKasopefoluwa O Akinbamijo, Ifeoluwa R Malmberg, Candace Griffith, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Lung cancer in West Sweden 1976-1985. A study of trends and survival with special reference to surgical treatmentR Malmberg, B Bergman, I Branehög, et al.
Proceedings of the Clinical Dialysis and Transplant Forum|January 1, 1973
Long-term kidney preservation with a new plasma perfusateL H Toledo-Pereyra, R M Condie, R Malmberg, et al.
Surgery, Gynecology & Obstetrics|June 1, 1974
A fibrinogen-free plasma perfusate for preservation of kidneys for one hundred and twenty hoursL H Toledo-Pereyra, R M Condie, R Malmberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugsJ B Sørensen, H H Hansen, P Dombernowsky, et al.
European Journal of Haematology|May 21, 2016
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencingErik B R Malmberg, Sara Ståhlman, Anna Rehammar, et al.
Pageof 2